Lindsey Watford
Family · Venice, FLNPI 1619536554
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 36.1% of the total. 2025 is the largest year on record at $18,455, more than ten times the $131 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $122.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$16K
- Revance Therapeutics, Inc.$11K
- Sun Pharmaceutical Industries Inc.$10K
- UCB, Inc.$2K
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$507
- plus $4K from 26 others
What the payments were for
- Consulting fees$14,93634%
- Speaking & faculty fees$16,78039%
- Travel & lodging$2,2755%
- Food & beverage$9,23221%
- Education$2561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 65 | $15,696 |
| Revance Therapeutics, Inc. | 15 | $10,540 |
| Sun Pharmaceutical Industries Inc. | 39 | $9,707 |
| UCB, Inc. | 27 | $2,006 |
| AbbVie(2 entities) | 46 | $1,332 |
| Regeneron Healthcare Solutions, Inc. | 17 | $507 |
| Galderma Laboratories, L.p. | 20 | $488 |
| Lilly USA, LLC | 17 | $418 |
| Sanofi | 13 | $296 |
| Merz North America, Inc. | 4 | $295 |
| Johnson & Johnson | 13 | $260 |
| Incyte Corporation | 10 | $224 |
| Novartis | 10 | $219 |
| Arcutis Biotherapeutics, Inc. | 3 | $170 |
| LEO Pharma Inc. | 7 | $167 |
| Amgen | 7 | $164 |
| Boehringer Ingelheim | 5 | $144 |
| Organogenesis Inc. | 5 | $124 |
| Botanix SB Inc | 1 | $120 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $95 |
| Almirall LLC | 3 | $86 |
| Biofrontera Inc. | 3 | $64 |
| Convatec Inc. | 3 | $56 |
| Pfizer | 3 | $51 |
| Boston Scientific | 2 | $50 |
| Genentech USA, Inc. | 5 | $48 |
| Verrica Pharmaceuticals Inc. | 2 | $46 |
| Dermavant Sciences, Inc. | 2 | $42 |
| Journey Medical Corporation | 1 | $20 |
| Smith+Nephew | 1 | $19 |
| EPI Health, LLC | 1 | $16 |
| Organon | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,479 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $103,583 |
| Dupixent PenDupilumab | 24 | $89,099 |
| Clobetasol Propionate | 33 | $1,644 |
| Doxycycline Hyclate | 81 | $1,626 |
| Ketoconazole | 90 | $1,347 |
| Triamcinolone Acetonide | 90 | $651 |
| Minocycline Hcl | 14 | $575 |
| Clindamycin Phosphate | 15 | $425 |
| Mupirocin | 67 | $419 |
Paid to pharmacies, not to this prescriber.
Other family in Venice
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.